UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

Diagnosis and treatment of chronic constipation – a European perspective

Neurogastroenterology and motility, 2011-08, Vol.23 (8), p.697-710

2011

Volltextzugriff (PDF)

Functional bowel disorders and functional abdominal pain

Gut, 1999-09, Vol.45 (suppl 2), p.II43-ii47

1999

Volltextzugriff (PDF)

Levels of satisfaction with current chronic constipation treatment options in Europe – an internet survey

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.137-145

2013

Volltextzugriff (PDF)

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Neurogastroenterology and motility, 2010-09, Vol.22 (9), p.991-e255

2010

Volltextzugriff (PDF)

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1655-1666

2001

Volltextzugriff (PDF)

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

Current medical research and opinion, 2008-12, Vol.24 (12), p.3503-3512

2008

Volltextzugriff (PDF)

A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians

Neurogastroenterology and motility, 2008-10, Vol.20 (10), p.1103-1109

2008

Volltextzugriff (PDF)

Systematic review: cardiovascular safety profile of 5‐ HT 4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting

Alimentary pharmacology & therapeutics, 2003-08, Vol.18 (3), p.291-301

2003

Volltextzugriff (PDF)

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.11-20

2005

Volltextzugriff (PDF)

Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease

Gut, 1996-08, Vol.39 (2), p.151-154

1996

Volltextzugriff (PDF)

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

BMJ, 1999-02, Vol.318 (7182), p.502-507

International edition, 1999

Volltextzugriff (PDF)

Role of Alimentation in Irritable Bowel Syndrome

Digestion, 2003-01, Vol.67 (4), p.225-233

2003

Volltextzugriff (PDF)

Paradoxical sphincter contraction is rarely indicative of anismus

Gut, 1997-08, Vol.41 (2), p.258-262

1997

Volltextzugriff (PDF)

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

Journal of medical economics, 2009-12, Vol.12 (4), p.371-383

2009

Volltextzugriff (PDF)

Controlling defecation: to be (predator) or not to be (prey), that is the question

Zeitschrift fur Gastroenterologie, 2015-05, Vol.53 (5), p.460

2015

Volltextzugriff (PDF)

The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients

Journal of international medical research, 2011-02, Vol.39 (1), p.41-50

2011

Volltextzugriff (PDF)

189 Oral prolonged release (PR) oxycodone/naloxone combination reduces opioid-induced bowel dysfunction (OIBD) in patients with severe chronic pain

European journal of pain, 2007-06, Vol.11 (1), p.82-82

2007

Volltextzugriff (PDF)

Three year follow up of patients with gastrooesophageal reflux disease

Gut, 1992-08, Vol.33 (8), p.1016-1019

1992

Volltextzugriff (PDF)

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Gut, 2005-12, Vol.54 (12), p.1707-1713

2005

Volltextzugriff (PDF)

Clinical response to dietary fiber treatment of chronic constipation

The American journal of gastroenterology, 1997, Vol.92 (1), p.95-98

1997

Volltextzugriff (PDF)

A prematurely terminated journey

Gut, 2011-05, Vol.60 (5), p.630-630

2011

Volltextzugriff (PDF)

Interobserver agreement in defecography--an international study

Zeitschrift für Gastroenterologie, 1998-04, Vol.36 (4), p.273

1998

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(186)
Deutsch
(119)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(193)
Life Sciences & Biomedicine
(140)
Science & Technology
(140)
Gastroenterology & Hepatology
(107)
Female
(87)
Male
(79)
Biological And Medical Sciences
(74)
Medical Sciences
(72)
Adult
(65)
Middle Aged
(63)
Gastroenterology. Liver. Pancreas. Abdomen
(51)
Other Diseases. Semiology
(47)
Aged
(43)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(42)
Chronic Disease
(25)
Constipation
(24)
Constipation - Drug Therapy
(24)
Double-Blind Method
(24)
Constipation - Physiopathology
(21)
Irritable Bowel Syndrome
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Diagnosis and treatment of chronic constipation – a European perspective

Functional bowel disorders and functional abdominal pain

Levels of satisfaction with current chronic constipation treatment options in Europe – an internet survey

A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians

Systematic review: cardiovascular safety profile of 5‐ HT 4 agonists developed for gastrointestinal disorders

Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

Role of Alimentation in Irritable Bowel Syndrome

Paradoxical sphincter contraction is rarely indicative of anismus

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

Controlling defecation: to be (predator) or not to be (prey), that is the question

The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients

189 Oral prolonged release (PR) oxycodone/naloxone combination reduces opioid-induced bowel dysfunction (OIBD) in patients with severe chronic pain

Three year follow up of patients with gastrooesophageal reflux disease

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Clinical response to dietary fiber treatment of chronic constipation

Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019

A prematurely terminated journey

Interobserver agreement in defecography--an international study

Suchergebnisse filtern